1. Hydrogen Sulfide (H2S)-Releasing Compounds: Therapeutic Potential in Cardiovascular Diseases
   Lei Zhang et al, 2018, Front. Pharmacol. CrossRef
2. Treating the bone to protect the heart: potential newer mechanisms and targets
   Gianluca Iacobellis, 2019, The American Journal of the Medical Sciences CrossRef
3. MicroRNA‑125a‑mediated regulation of the mevalonate signaling pathway contributes to high glucose‑induced proliferation and migration of vascular smooth muscle cells
   Dan Ye et al, 2020, Mol Med Report CrossRef
4. Geranylgeranyl Transferase-I Knockout Inhibits Oxidative Injury of Vascular Smooth Muscle Cells and Attenuates Diabetes-Accelerated Atherosclerosis.
   Guo-Ping Chen et al, 2020, J Diabetes Res CrossRef
5. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System
   Chi Zhang et al, 2021 CrossRef
6. Targeting Small GTPases and Their Prenylation in Diabetes Mellitus
   Edyta Gendaszewska-Darmach et al, 2021, J. Med. Chem. CrossRef
7. Hydrogen sulfide in diabetic complications revisited: the state of the art, challenges, and future directions
   Haijian Sun et al, 2022, Antioxidants & Redox Signaling CrossRef
8. Alendronate-decorated strontium-containing bioactive glass nanoparticles with dual osteogenic and anti-osteoclastic effects for osteoporosis
   Mengen Zhao et al, 2023, Journal of Non-Crystalline Solids CrossRef